Generalized asymptomatic skin coloured papular eruption
DOI:
https://doi.org/10.66344/jpad.27.3.2017.1121References
Rongioletti F, Rebora A. Cutaneous mucinoses: Microscopic criteria for diagnosis. Am J Dermatopathol. 2001;23(3):257-67.
Sterling JC. Cutaneous mucinosis. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R,C Daniel. Rooks Text book of dermatology. 9th ed. London: Willey-Blackwell; 2016. P. 59.1-59.18.
Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol.2001;44:273-81.
Bragg J, Soldano AC, Latkowski JA. Papular mucinosis (discrete papular lichen myxedematosus). Dermatol Online J. 2008;14(5):14.
Rongioletti F. Lichen myxedematosus (papular mucinosis): New concepts and perspectives for an old disease. Semin Cutan Med Surg.2006;25:100-4.
Clark BJ, Mowat A, Fallowfield ME, Lee FD. Papular mucinosis. Is the inflammatory cell infiltrate neoplastic? The presence of a monotypic plasma cell population demonstrated by in situ hybridization. Br J Dermatol. 1996;135:467-70.
Bata-Csorgo Z, Husz S, Foldes M, Korom I, Molnar K, Morvay M et al. Scleromyxedema. J Am Acad Dermatol. 1999;41:343-6.
Rothfleisch JE. Papular mucinosis. Dermatology Online J. 2001;7(2):13.
Sa DK, Ghosh A, Kumar P, Gharami RC. A case of localized papular mucinosis showing excellent response to cyclophosphamide. Indian J Dermatol. 2014; 59(2):202-4
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.